Hyderabad, India-based Bharat Biotech, announced a partnership with Spanish biopharmaceutical company BioFabri to develop, manufacture and distribute a new tuberculosis vaccine. MTBVAC, a live attenuated vaccine, is considered one of the most promising vaccine candidates in the current global TB vaccine pipeline. Biofabri is part of the Zendal Group based in...